Research supports grief-focused psychotherapy for some people with persistent, impairing grief. That does not mean every bereaved person needs treatment or that a private clinic’s results match a research trial. Read evidence by asking who participated, what was compared, what improved and what remains uncertain.
Distinguish a treatment study from a provider claim
A trial evaluates a particular intervention under defined conditions. A provider may offer that intervention as one part of a broader programme, with different clinicians, participants and follow-up. The connection must be explained; a research citation alone does not establish a clinic’s success rate.
Ask whether the proposed therapist is trained in the approach, how it will be delivered and how progress will be reviewed. The prolonged grief therapy guide translates that discussion into appointment questions.
What one important randomized trial found
A 2016 randomized trial enrolled 395 bereaved adults with complicated grief. Participants receiving a structured grief treatment with placebo had a higher response rate than those receiving placebo with the study’s clinical management. Adding citalopram to the grief treatment did not significantly improve the grief response, although it improved depressive symptoms. Shear and colleagues, JAMA Psychiatry, 2016.
These findings separate grief outcomes from depression outcomes. They do not establish that medication is never useful after bereavement. The sample and exclusion criteria also limit generalization: this was not a trial of all bereaved people, all medicines, or luxury residential treatment.
Use a short evidence checklist
| Question | Why it matters |
|---|---|
| Who was included? | Age, symptoms and other conditions affect relevance. |
| What was the comparison? | A testimonial cannot separate treatment effects from other changes. |
| What counted as improvement? | Grief symptoms, depression and daily functioning are different outcomes. |
| Who was followed up? | Missing follow-up can change how an apparent success rate should be interpreted. |
| How long did follow-up last? | Finishing a programme is different from sustained improvement. |
Evidence does not turn ordinary grief into an illness
A clinical trial in people with severe, persistent symptoms does not imply that everyone should begin that treatment after a death. Bereavement support, practical help and community contact may suit different needs. The American Psychiatric Association’s overview describes prolonged grief disorder as a specific clinical condition.
An individual assessment should connect a treatment recommendation with the difficulties present. See levels of grief support for the distinction between companionship, peer support and clinical care.
Ask for a review plan you can understand
Before starting, agree what you hope will become more manageable and when to review progress. A questionnaire may be useful alongside your account of daily life. Ask what will happen if you do not improve, and whether another assessment or treatment approach may be needed.
For private programmes, request the definition, denominator and follow-up period behind any outcome claim. Do not compare percentages from unlike groups as though they were a league table. Our comparison methodology and progress guide explain the limits of provider comparisons.